Agilent Technologiesvs.Danaher
A vs DHR · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Danaher is about 3.7× larger than Agilent Technologies by market cap; Agilent Technologies trades at the lower P/E (26.8 vs 38.1); year to date, Agilent Technologies leads (−1.3% vs −13.0%).
Side by side
| A | DHR | |
|---|---|---|
| Market cap | $37.9B | $141B |
| Price | $134.29 | $199.05 |
| Today | +0.5% | +1.6% |
| Return YTD | −1.3% | −13.0% |
| Return 1Y | +8.2% | −3.1% |
| P/E | 26.8 | 38.1 |
| P/S | 5.2 | 5.7 |
| P/B | 5.3 | 2.7 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Agilent TechnologiesA
American manufacturer of analytical instruments and laboratory solutions for life science, diagnostics and chemical analysis.
Full A profile →DanaherDHR
American group focused on life science and diagnostics — bioprocessing (Cytiva), molecular diagnostics and laboratory solutions.
Full DHR profile →More comparisons in Life science tools
See where A and DHR sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →